Use of long-acting depot progestogen in domililiary family planning.
نویسندگان
چکیده
منابع مشابه
Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users.
OBJECTIVE To describe women who accept single-rod progestogen contraceptive implants (Implanon; N.V. Organon, Oss, Netherlands) from community health workers in Ethiopia and to assess whether community-based provision addresses unmet need for contraception. METHODS Women who accepted Implanon during training events in 4 regions were asked about their characteristics and use of family planning...
متن کاملFamily Planning in Islam
ازدیاد توالد و تناسل اگرچه مطلوب شارع مقدس بوده و در حد امکان نباید جلوگیری شود ولیکن اصل اساسی تر از آن چگونگی تربیت و تأمین آینده ای بهتر برای فرزندان است، از اینرو غالب اندیشمندان اسلامی، مسئله تنظیم خانواده را جایز می دانند.
متن کاملIncreasing use of long-acting reversible contraception.
23 p23 UPDATE informs you of changes in clinical practice. This week: contraception p26 PrAcTicAl PrOcEDUrEs illustrates procedures. This week: removing an indwelling catheter p28 gUiDED lEArNiNg includes online cPD. This week: law on advance decisions p30 DEVElOPmENT shows how nurses are developing practice. This week: evaluating telemedicine p32 rEsEArcH presents research papers. This week: s...
متن کاملLong-Acting Reversible Contraceptives: An Important Focus at the 2016 International Conference on Family Planning
The fourth International Conference on Family Planning (ICFP) was held in Nusa Dua, Indonesia, on January 25–28, 2016. Themed ‘‘Global Commitments, Local Actions,’’ the conference stressed the importance of global and local partnerships to shape and influence the role and contributions of family planning in attain ing health and development goals, in particular the new Sustainable Development ...
متن کاملCardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
Cardiovascular disease is the most severe complication of acromegaly accounting for the increased mortality of these patients. Recently, the slow-release form of octreotide (OCT; Sandostatin LAR, OCT-LAR), for im injection every 28 days, was reported to induce suppression of GH levels below 7.5 mU/L (2.5 microg/L) in 39-75% of patients, and normalization of insulin-like growth factor (IGF)-I le...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1976
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.2.6049.1435